About EB Research Partnership
EB Research Partnership is a company based in New York (United States). It operates as a Donation / Grant-Based. EB Research Partnership offers products and services including EB Research Funding.
- Headquarter New York, United States
- SectorsHealthcare
- Phone•••• ••••
- Website ebresearch.org
- Social LinkedIn YouTube
Products & Services of EB Research Partnership
EB Research Partnership offers a comprehensive portfolio of products and services, including EB Research Funding.
Funding is provided for Epidermolysis Bullosa cure research.
Apps and channels of EB Research Partnership
its YouTube channel EB Research Partnership has 4.69K subscribers and 30 videos.
Videos from EB Research Partnership
The most watched videos on EB Research Partnership's YouTube channel, EB Research Partnership (4.69K subscribers). Click a video to play it here.
More on EB Research Partnership.
Similar companies to EB Research Partnership
10 companies that operate in the same segment as EB Research Partnership (Rare Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing. | 2013 | Basel, Basel-stadt, Switzerland | USD 127 M | USD 37.31 M | 393 | |
Gene therapies for rare diseases are developed to treat patients. | 2020 | Columbus, Ohio, United States | USD 250 M | – | – | |
Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases | 2015 | Cambridge, Massachusetts, United States | USD 114.67 M | – | 45 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals. | 2019 | Menlo Park, California, United States | USD 90 M | USD 175.11 M | 427 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EB Research Partnership
EB Research Partnership is headquartered in New York, United States. It is registered at New York, New York, United States.
Support is extended by EB Research Partnership to find cures for Epidermolysis Bullosa, a rare genetic skin disorder. Efforts are focused on accelerating research through innovative models and financial responsibility. The organization operates in the rare disease sector, aiming to heal and cure EB by 2030. Solutions are developed to benefit over 400 million people affected by rare diseases globally. Life-saving treatments are advanced for EB families worldwide.
EB Research Partnership offers EB Research Funding.